Article detail · 2024
Exploring improved strategies for therapeutic studies and biological activities of novel zinc and indium phthalocyanines
- Year
- 2024
- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- YÖKSİS venue Dalton Transactions
- Catalog match (ISSN) Dalton Transactions
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
OpenAlex · English
values of 0.91 and 0.94, respectively. Furthermore, the evaluation for biological properties revealed that both D3 and D4 exhibit significant antidiabetic properties, DPPH radical scavenging activity, DNA cleavage, antimicrobial activity, biofilm inhibition, and microbial cell viability impacts, both with and without photodynamic therapy. Notably, D3 and D4 achieved antimicrobial cell viability inhibition rates of 84.67 ± 4.67% and 98.32 ± 5.96%, respectively, showcasing their effectiveness in photodynamic antimicrobial therapy. Overall, the study highlights the potential of these phthalocyanine complexes as advanced photosensitizers, with strong singlet oxygen generation and promising biological activities, paving the way for future therapeutic applications.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
18 citations
OpenAlex cited_by_count (cache / database)
47 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- Bulk Passivation of Perovskite Films With Phthalocyanine Derivative for Enhanced Perovskite Solar Cells Efficiency and Stability 2025
- Development of novel Phthalocyanine/Graphene oxide Composite: Potential usage for Sono/Photochemical Applications, and the treatment of type-2 diabetes and Alzheimers disease 2025
- Development of novel Phthalocyanine/Graphene oxide Composite: Potential usage for Sono/Photochemical Applications, and the treatment of type-2 diabetes and Alzheimers disease 2025
- Development of novel Phthalocyanine/Graphene oxide Composite: Potential usage for Sono/Photochemical Applications, and the treatment of type-2 diabetes and Alzheimers disease 2025
- Development of novel Phthalocyanine/Graphene oxide Composite: Potential usage for Sono/Photochemical Applications, and the treatment of type-2 diabetes and Alzheimers disease 2025
- Development of novel Phthalocyanine/Graphene oxide Composite: Potential usage for Sono/Photochemical Applications, and the treatment of type-2 diabetes and Alzheimers disease 2025
- Development of novel Phthalocyanine/Graphene oxide Composite: Potential usage for Sono/Photochemical Applications, and the treatment of type-2 diabetes and Alzheimers disease 2025
- 2D and 3D in vitro photodynamic activities of tetra-substituted symmetric water-soluble cationic zinc(II) phthalocyanines on cancer 2025
- 2D and 3D in vitro photodynamic activities of tetra-substituted symmetric water-soluble cationic zinc(II) phthalocyanines on cancer 2025
- 2D and 3D in vitro photodynamic activities of tetra-substituted symmetric water-soluble cationic zinc(II) phthalocyanines on cancer 2025